Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses

• Published in: Nature reviews. Immunology Vol. 23; no. 3; pp. 189 - 199
• Main Authors: Chen, Yanjia, Zhao, Xiaoyu, Zhou, Hao, Zhu, Huanzhang, Jiang, Shibo, Wang, Pengfei
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 01.03.2023; Nature Publishing Group
• Subjects: 631/250/2152/2153/1291; 631/326/596/2558; 631/326/596/4130; Antibodies; Antibodies, Neutralizing; Biomedical and Life Sciences; Biomedicine; Broadly Neutralizing Antibodies; Coronaviruses; COVID-19; COVID-19 vaccines; Drug development; Global economy; Humans; Immunology; Pandemics; Public health; Review; Review Article; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Vaccines

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recently emerged pathogenic human coronavirus that belongs to the sarbecovirus lineage of the genus Betacoronavirus. The ancestor strain has evolved into a number of variants of concern, with the Omicron variant of concern now having...